Anonymous
Guest
Anonymous
Guest
I am hearing from an inside source that Lilly Oncology will cut it's salesforce 40% by Fall 2012. One show pony, no merit increases, no new products for at least 2 years, sluggish Alimta sales, region directors leaving. Is this the real "transformation" project? CP did say that they are re-evaluating the biad structure? Is "transformation project" simply code for job cuts? Here it comes.